These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18038625)

  • 1. [Comparative analysis of analgesic activities of dermorphin, [DPro6]-dermorphin, and their C-terminal tripeptides].
    Guzevatykh LS; Voronina TA; Emel'ianova TG; Andreeva LA; Gromovykh PS; Miasoedov NF; Seredenin SB
    Izv Akad Nauk Ser Biol; 2007; (5):577-82. PubMed ID: 18038625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analgesic activity of dermorphin and its proline analogs].
    Guzevatykh LS; Valuĭskiĭ DV; Voronina TA; Emel'ianova TG; Andreeva LA; Alfeeva LIu; Seredenin SB; Miasoedov NF
    Eksp Klin Farmakol; 2005; 68(2):8-10. PubMed ID: 15934358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal action of dermorphin, an extremely potent opioid peptide from frog skin.
    Stevens CW; Yaksh TL
    Brain Res; 1986 Oct; 385(2):300-4. PubMed ID: 2877713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analgesic activity of dipeptide Tyr-Pro].
    Guzevatykh LS; Voronina TA; Emel'ianova TG; Andreeva LA; Alfeeva LIu; Seredenin SB; Miasoedov NF
    Izv Akad Nauk Ser Biol; 2008; (1):61-7. PubMed ID: 18491563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo opioid activity of [DPro(6)]dermorphin, a new dermorphin analogue.
    Broccardo M; Usenko AB; Uranova MG; Guzevatykh LS; Kamensky AA; Andreeva LA; Alfeeva LY; Myasoedov NF; Giannini E; Improta G; Emel'yanova TG
    Peptides; 2003 Mar; 24(3):419-28. PubMed ID: 12732340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.
    Shimoyama M; Szeto HH; Schiller PW; Tagaito Y; Tokairin H; Eun Cm; Shimoyama N
    Pharmacology; 2009; 83(1):33-7. PubMed ID: 18987489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of divalent cations on the analgesic effect of opioid and non-opioid drugs.
    Assi AA
    Pharmacol Res; 2001 Jun; 43(6):521-9. PubMed ID: 11419960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788.
    Paakkari P; Feuerstein G
    Neuropharmacology; 1988 Oct; 27(10):1007-12. PubMed ID: 2907115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dermorphin on thermoregulation in rats at selected ambient temperatures.
    Emel'yanova TG; Usenko AB; Deigin VI; Yarova EP; Kamensky AA
    Peptides; 1996; 17(2):241-5. PubMed ID: 8801528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
    Hernández-Delgadillo GP; Cruz SL
    Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
    Negri L; Lattanzi R; Tabacco F; Scolaro B; Rocchi R
    Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effect of endomorphin-1.
    Li ZH; Shan LD; Jiang XH; Guo SY; Yu GD; Hisamitsu T; Yin QZ
    Acta Pharmacol Sin; 2001 Nov; 22(11):976-80. PubMed ID: 11749786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
    Negri L; Lattanzi R; Tabacco F; Melchiorri P
    Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermorphin, a new peptide from amphibian skin, inhibits the nociceptive thalamic neurons firing rate evoked by noxious stimuli.
    Braga PC; Tiengo M; Biella G; Dall'Oglio G; Fraschini F
    Neurosci Lett; 1984 Nov; 52(1-2):165-9. PubMed ID: 6527833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate and acetylcholine-independent analgesic actions of crotoxin isolated from crotalus durissus terrificus venom.
    Zhang HL; Han R; Chen ZX; Chen BW; Gu ZL; Reid PF; Raymond LN; Qin ZH
    Toxicon; 2006 Aug; 48(2):175-82. PubMed ID: 16857228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory and locomotor stimulation by low doses of dermorphin, a mu1 receptor-mediated effect.
    Paakkari P; Paakkari I; Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1990 Jan; 252(1):235-40. PubMed ID: 1967644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
    Yaksh TL; Malmberg AB; Ro S; Schiller P; Goodman M
    J Pharmacol Exp Ther; 1995 Oct; 275(1):63-72. PubMed ID: 7562596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of endogenous opioid system in scorpion toxin-induced antinociception in mice.
    Martin-Eauclaire MF; Abbas N; Sauze N; Mercier L; Berge-Lefranc JL; Condo J; Bougis PE; Guieu R
    Neurosci Lett; 2010 Sep; 482(1):45-50. PubMed ID: 20619318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.